Susunod

Auto-play

Dr. Yasmin Thanavala on targeted therapy for liver cancer

2 Mga view • 06/28/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play